
Syngene has announced the launch of its new protein production platform, which will utilise a cell line and transposon-based technology …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

